2012-10-04 07:54:15 - Fast Market Research recommends "Skin Ulcers - Pipeline Review, H2 2012" from Global Markets Direct, now available

Global Markets Direct's, 'Skin Ulcers - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Skin Ulcers, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Skin Ulcers. Skin Ulcers - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated

disease.


Full Report Details at
- www.fastmr.com/prod/468486_skin_ulcers_pipeline_review_h2_2012.a ..


Scope

* A snapshot of the global therapeutic scenario for Skin Ulcers.
* A review of the Skin Ulcers products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Skin Ulcers pipeline on the basis of route of administration and molecule type.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Skin Ulcers.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Skin Ulcers pipeline depth and focus of Indication therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Skin Ulcers Overview
Therapeutics Development
An Overview of Pipeline Products for Skin Ulcers
Skin Ulcers Therapeutics under Development by Companies
Skin Ulcers Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Skin Ulcers Therapeutics - Products under Development by Companies
Skin Ulcers Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Skin Ulcers Therapeutics Development
Galderma S.A.
Skin Ulcers - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
HO/03/03 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
oxandrolone - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Thymosin beta-4 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
GK567 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Skin Ulcers Therapeutics - Discontinued Products
Skin Ulcers Therapeutics - Dormant Products
Skin Ulcers - Product Development Milestones
Featured News & Press Releases
Dec 08, 2010: DPT Receives FDA Approval To Commercially Manufacture Collagenase SANTYL Sterile Ointment
Jan 09, 2009: RegeneRx Reports Phase II Pressure Ulcer Trial Results
Sep 24, 2008: HealOr Announces $15 Million Investment Led By Mori Arkin To Heal Chronic Wounds
Sep 22, 2008: RegeneRx/Sigma-Tau Completes Patient Enrollment Of Second Phase II Clinical Trial With RGN-137
Aug 20, 2008: RegeneRx Completes Patient Enrollment Of First Phase II Clinical Trial
Apr 26, 2008: HealOr's Leading Drug HO/03/03 Receives Recognition From The Wound Healing Society In The SAWC&WHS 2008 Conference In San Diego
Nov 02, 2004: RegeneRx Gets Cleared To Initiate Phase II Clinical Trial With TB4 For Chronic Pressure Ulcers
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Number of Products Under Development for Skin Ulcers, H2 2012
Products under Development for Skin Ulcers - Comparative Analysis, H2 2012
Number of Products under Development by Companies, H2 2012
Number of Products under Investigation by Universities/Institutes, H2 2012
Comparative Analysis by Late Stage Development, H2 2012
Comparative Analysis by Mid Clinical Stage Development, H2 2012
Products under Development by Companies, H2 2012
Products under Investigation by Universities/Institutes, H2 2012
Galderma S.A., H2 2012
Assessment by Monotherapy Products, H2 2012
Assessment by Stage and Route of Administration, H2 2012
Assessment by Stage and Molecule Type, H2 2012
Skin Ulcers Therapeutics - Discontinued Products
Skin Ulcers Therapeutics - Dormant Products

List of Figures
Number of Products under Development for Skin Ulcers, H2 2012
Products under Development for Skin Ulcers - Comparative Analysis, H2 2012

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=468486&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.